Sfoglia per Autore "Tsantouli, A. G."
Items 1-6 di 6
-
Dynamics of pneumococcal carriage among day-care center attendees during the transition from the 7-valent to the higher-valent pneumococcal conjugate vaccines in Greece
Grivea, I. N.; Priftis, K. N.; Giotas, A.; Kotzia, D.; Tsantouli, A. G.; Douros, K.; Michoula, A. N.; Syrogiannopoulos, G. A. (2014)Background: In Greece recently, higher-valent pneumococcal conjugate vaccines (PCVs) replaced the 7-valent (PCV7); the 10-valent (PCV10) became available in May 2009 and the 13-valent (PCV13) in June 2010. Methods: We ... -
Dynamics of Streptococcus pneumoniae nasopharyngeal carriage with high heptavalent pneumococcal conjugate vaccine coverage in Central Greece
Grivea, I. N.; Tsantouli, A. G.; Michoula, A. N.; Syrogiannopoulos, G. A. (2011)In order to study whether the use of the heptavalent pneumococcal conjugate vaccine (PCV7) led to a shift in the Streptococcus pneumoniae serotypes distribution and whether it modified the resistance to antibiotics, 2649 ... -
Impact of heptavalent pneumococcal conjugate vaccine on nasopharyngeal carriage of penicillin-resistant Streptococcus pneumonide among day-care center attendees in central Greece
Grivea, I. N.; Panagiotou, M.; Tsantouli, A. G.; Syrogiannopoulos, G. A. (2008)Background: In Greece, the heptavalent pneumococcal conjugate vaccine (PCV7) became available in October 2004 and it was incorporated into the national immunization schedule in January 2006. Methods: In February 2005, a ... -
Interaction of the heptavalent pneumococcal conjugate vaccine and the use of individual antibiotics among children on nasopharyngeal colonization with erythromycin-resistant Streptococcus pneumoniae
Grivea, I. N.; Tsantouli, A. G.; Chryssanthopoulou, D. C.; Syrogiannopoulos, G. A. (2010)The purpose of this study was to assess the complex interaction of the heptavalent pneumococcal conjugate vaccine (PCV7) and individual classes of antimicrobial agents on the nasopharyngeal carriage of erythromycin-resistant ... -
Macrolide resistance determinants among Streptococcus pneumoniae isolates from carriers in Central Greece
Grivea, I. N.; Sourla, A.; Ntokou, E.; Chryssanthopoulou, D. C.; Tsantouli, A. G.; Syrogiannopoulos, G. A. (2012)Background: We sought to characterize the temporal trends in nasopharyngeal carriage of macrolide-resistant pneumococci during a period with increased heptavalent pneumococcal conjugate vaccine (PCV7) coverage in Central ... -
Seven-year surveillance of emm types of pediatric Group A streptococcal pharyngitis isolates in Western Greece
Syrogiannopoulos, G. A.; Grivea, I. N.; Al-Lahham, A.; Panagiotou, M.; Tsantouli, A. G.; Michoula Ralf René Reinert, A. N.; van der Linden, M. (2013)An experimental 26-valent M protein Group A streptococcal (GAS) vaccine has entered clinical studies. Pharyngeal GAS emm type surveillances in different areas and time-periods enhance the understanding of the epidemiology ...